$0.5928+4.88%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Jasper Therapeutics last closed at $0.5928 (+4.88%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.5×. Its overall grade ranks 663 of 741 stocks in Healthcare.
About this company
Jasper Therapeutics last closed at $0.5928 (+4.88%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall D · 663/741
Valuation grade D
Related stocks
- AmgenCompetitor
골수/조혈 및 항체 기반 혈액질환 치료제 개발 영역에서 경쟁
- NovartisCompetitor
희귀혈액질환·면역질환 바이오의약품 분야의 글로벌 경쟁사
- Regeneron PharmaceuticalsCompetitor
항체·면역질환/혈액질환 파이프라인에서 경쟁 가능한 대형 바이오텍
About Jasper Therapeutics
- What technical signals does Jasper Therapeutics (JSPR) have?
- Jasper Therapeutics current technical signals: no active technical signal.
- Is Jasper Therapeutics a cup-and-handle pattern?
- No. Jasper Therapeutics has no valid Cup signal right now.
- What published figures are available for Jasper Therapeutics?
- Market cap: $16.59M. Trailing 12 months PER: -0.5×. Latest quarter PBR: 12.04×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Jasper Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy